A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

Brain

Volumn 122, Issue 12, 1999, Pages 2279-2295

  Lucchinetti, Claudia ^a   Brück, Wolfgang ^b   Parisi, Joseph ^a   Scheithauer, Bernd ^a   Rodriguez, Moses ^a   Lassmann, Hans ^c  

^a MAYO CLINIC   (United States)

^b Institute of Neuropathology   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Demyelination; Multiple sclerosis; Oligodendrocytes; Pathology

Indexed keywords

GLYCOPROTEIN; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; BIOPSY; BRAIN INJURY; CELL DENSITY; CELLULAR DISTRIBUTION; DEMYELINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMYELINIZATION; T LYMPHOCYTE; WHITE MATTER;

ADULT; CELL COUNT; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN PROTEOLIPID PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGODENDROGLIA; RNA, MESSENGER;

EID: 0345633543     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.12.2279     Document Type: Article

References (60)

1. Archelos JJ, Trotter J, Previtali S, Weisshrich B, Toyka KV, Hartung HP. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis [see comments]. Ann Neurol 1998; 43: 15-24. Comment in Ann Neurol 1998; 43: 4-6.
2. Archelos JJ, Trotter J, Previtali S, Weisshrich B, Toyka KV, Hartung HP. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis [see comments]. Ann Neurol 1998; 43: 15-24. Comment in Ann Neurol 1998; 43: 4-6.
3. Bornstein MB, Appel SH. The application of tissue culture to the study of experimental 'allergic' encephalomyelitis. I. Patterns of demyelination. J Neuropathol Exp Neurol 1961; 20: 141-7.
4. Breitschopf H, Suchanek G, Gould RM, Colman DR, Lassmann H. In situ hybridization with digoxigenin-labeled probes. Sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol (Berl) 1992; 84: 581-7.
5. Brosnan CF, Stoner GL, Bloom BR, Wisniewski HM. Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination. J Immunol 1977; 118: 2103-10.
6. Brück W, Schmied M, Suchanek G, Brück Y, Breitschopf H, Poser S, et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994; 35: 65-73.
7. Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995; 38: 788-96.
8. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein. and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J Neurochem 1989; 52: 296-304.
9. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996; 184: 2361-70.
10. Diemel LT, Copelman CA, Cuzner ML. Macrophages in CNS remyelination: friend or foe? [Review]. Neurochem Res 1998; 23: 341-7.
11. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 1996; 184: 1513-618.
12. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9.
13. Freedman MS, Ruijs TC, Selin LK, Antel JP. Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes [see comments]. Ann Neurol 1991; 30: 794-800. Comment in: Ann Neurol 1992; 32: 410-1.
14. Freedman MS, Ruijs TC, Selin LK, Antel JP. Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes [see comments]. Ann Neurol 1991; 30: 794-800. Comment in: Ann Neurol 1992; 32: 410-1.
15. Gay FW, Drye TJ, Dick GW, Esiri MM. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: identification and characterization of the primary demyelinating lesion. Brain 1997; 120: 1461-83.
16. Griot C, Vandevelde M, Richard A, Peterhans E, Stocker R. Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Radic Res Commun 1990; 11: 181-93.
17. Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975; 38: 585-91.
18. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftenr Neurol 1983; 25: 1-135.
19. Lassmann H, Wisniewski HM. Chronic relapsing experimental allergic encephalomyelitis: Morphological sequence of myelin degradation. Brain Res 1979; 169: 357-68.
20. Lassmann H, Raine CS, Antel J, Prineas JW. Immunopathology of multiple sclerosis. Report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 1998; 86: 213-7.
21. Linington C, Engelhardt B, Kapocs G, Lassmann H. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 1992; 40: 219-24.
22. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. [Review]. Brain Pathol 1996; 6: 259-74
23. Ludwin SK. Proliferation of mature oligodendrocytes after trauma to the central nervous system. Nature 1984; 308: 274-5.
24. Ludwin SK, Bakker DA. Can oligodendrocytes attached to myelin proliferate? J Neurosci 1988; 8: 1239-44.
25. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 9. Amsterdam: North Holland; 1970. p. 217-309.
26. Matthieu JM, Amiguet P. Myelin/oligodendrocyte glycoprotein expression during development in normal and myelin-deficient mice. Dev Neurosci 1990; 12: 293-302.
27. Mews I, Bergmann M, Bunkowski S, Gullotta F, Brück W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Multiple Sclerosis 1998; 4: 55-62.
28. Miller DJ, Rodriguez M. A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol 1995; 154: 2460-9.
29. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117: 1311-22.
30. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
31. Prineas J. Pathology of the early lesion in multiple sclerosis. [Review]. Hum Pathol 1975; 6: 531-54.
32. Prineas JW. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, Klawaus HL, editors. Handbook of clinical neurology, Vol. 47. Amsterdam: Elsevier; 1985. p. 337-95.
33. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, et al. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 1989; 61: 489-503.
34. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain 1993; 116: 681-93.
35. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor-a. Proc Natl Acad Sci USA 1995; 92: 11294-8.
36. Puckett C, Hudson L, Ono K, Friedrich V, Benecke J, Dubois-Dalcq M, et al. Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J Neurosci Res 1987; 18: 511-8.
37. Raine CS, Scheinberg L, Waltz JM. Multiple sclerosis: oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 1981; 45: 534-46.
38. Rodriguez M, Scheithauer B. Ultrastructure of multiple sclerosis. Ultrastructural Pathol 1994; 18: 3-13.
39. Rodriguez M, Leibowitz JL, Lampert PW. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 1983; 13: 426-33.
40. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis [see comments]. Mayo Clin Proc 1993; 68: 627-36. Comment in: Mayo Clin Proc 1993; 68: 711-2.
41. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis [see comments]. Mayo Clin Proc 1993; 68: 627-36. Comment in: Mayo Clin Proc 1993; 68: 711-2.
42. Sanders V, Conrad AJ, Tourtellotte WW. On classification of post-mortem multiple sclerosis plaques for neuroscientists. J Neuroimmunol 1993; 46: 207-16.
43. Scolding N, Jones J, Compston DA, Morgan BP. Oligodendrocyte susceptibility to injury by T-cell perform. Immunology 1990; 70: 6-10.
44. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339-46.
45. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991a; 87: 949-54.
46. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 1991b; 147: 1522-9.
47. Sobel RA, Mitchell ME, Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990; 136: 1309-16.
48. Sriram S, Rodriguez M. Indictment of the microglia as the villain in multiple sclerosis. [Review]. Neurology 1997; 48: 464-70.
49. Storch M, Lassmann H. Pathology and pathogenesis of demyelinating diseases. [Review]. Curr Opin Neurol 1997; 10: 186-92.
50. Storch MK, Piddlesden S, Haltia M, livanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann Neurol 1998a; 43: 465-71.
51. Storch MK, Stefferl A, Brehm U, Weissert R, Wallström E, Kerschensteiner M, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998b; 8: 681-94.
52. Targett MP, Sussman J, Scolding N, O'Leary MT, Compston DA, Blakemore WF. Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain. Neuropathol Appl Neurobiol 1996; 22: 199-210.
53. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis [see comments]. N Engl J Med 1998; 338: 278-85. Comment in: N Engl J Med 1998; 338: 323-5.
54. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis [see comments]. N Engl J Med 1998; 338: 278-85. Comment in: N Engl J Med 1998; 338: 323-5.
55. Traugott U. Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J Neuroimmunol 1987; 16: 283-302.
56. Traugott U, Reinherz EL, Raine CS. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 1983; 4: 201-21.
57. Vass K, Lassmann H, Wekerle H, Wisniewski HM. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol (Berl) 1986; 70: 149-60.
58. Washington R, Burton J, Todd RF 3rd, Newman W, Dragovic L, Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 1994; 35: 89-97.
59. Wolswijk G. Oligodendrocyte precursor cells in chronic multiple sclerosis lesions. Multiple Sclerosis 1997; 3: 168-9.
60. Woodroofe MN, Cuzner ML. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 1993; 5: 583-8.